J. Garber

发表

Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate.

Stephanie L. Lee, J. Garber, H. Rosen, 1998, The Journal of clinical endocrinology and metabolism.

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

K Offit, C Varricchio, E. Thomson, 1997, JAMA.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

J. Cuzick, A. Tutt, C. Denkert, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Identifying and assessing women at high risk for breast cancer

J. Garber, 2009, Breast Cancer Research.

Serum CTX: A New Marker of Bone Resorption That Shows Treatment Effect More Often Than Other Markers Because of Low Coefficient of Variability and Large Changes with Bisphosphonate Therapy

H. Rosen, A. Moses, J. Garber, 2000, Calcified Tissue International.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

E. Winer, J. Cuzick, A. Tutt, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

E. Winer, J. Cuzick, A. Tutt, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Benefits and risks of screening mammography in women with BRCA1 and BRCA2 mutations [4] (multiple letters)

E. Thomson, K. Offit, A. McTiernan, 1997 .

Utility of Biochemical Markers of Bone Turnover in the Follow-up of Patients Treated with Bisphosphonates

H. Rosen, A. Moses, J. Garber, 1998, Calcified Tissue International.

JAK2V617F-positive clonal hematopoiesis of indeterminate potential in pregnant women

J. Garber, I. Olkhovskiy, M. Stolyar, 2019, Obstetrics, Gynecology and Reproduction.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

E. Winer, J. Cuzick, A. Tutt, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

E. Thomson, K. Offit, A. McTiernan, 1997, JAMA.

Privacy in Genetics Research

K. Hudson, L. Biesecker, J. Murray, 1999, Science.

Screening for germ line TP53 mutations in breast cancer patients.

S. Friend, E. Hovig, J. Eyfjörd, 1992, Cancer research.

The Effect of PTH Antagonist BIM-44002 on Serum Calcium and PTH Levels in Hypercalcemic Hyperparathyroid Patients

H. Rosen, J. Garber, S. Greenspan, 1997, Calcified Tissue International.

Glycochenodeoxycholic Acid Does Not Increase Transforming Growth Factor-Beta Expression in Bile Duct Epithelial Cells or Collagen Synthesis in Myofibroblasts.

J. Garber, G. Minuk, Y. Gong, 2017, Journal of clinical and experimental hepatology.

Toxic bile acids do not increase transforming growth factor-beta expression in bile duct epithelial cells or collagen synthesis in myofibroblasts

J. Garber, G. Minuk, A. Wang, 2016 .